Xinli Henry Lin

1 Patent

• US119640042024

  Short in Vivo Half-life and in Vivo Unstable Recombinant Microplasmin, Pharmaceutical Composition Comprising Thereof and Method of Treating Thromboembolism Related Diseases Including Administration Thereof

  SHENZHEN BAY LABORATORY

  0 cites